Experimental studies and clinical observations in patients with STING-associated infantile vasculopathy have shown that individuals carrying gain-of-function mutations in TMEM173 are more likely to develop pulmonary fibrosis (35–37). The gene discussed is STING1; the disease is pulmonary fibrosis.